Holowesko Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Holowesko Partners's GILD Position: Q1 2021 in Review
Holowesko Partners sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 49,000 shares — an estimated $2.85M sold.
Holowesko Partners first reported a position in GILD in Q3 2015 and held it in 19 quarters. The position peaked at $98.7M in Q3 2017. 1,568 funds tracked by Wall St. Rank hold GILD as of Q1 2021.
- Holowesko Partners reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
- Holowesko Partners sold 49,000 Gilead Sciences shares in Q1 2021, an estimated $2.85M.
- Holowesko Partners first reported a position in Gilead Sciences in Q3 2015 and held it in 19 quarters.
- Holowesko Partners's Gilead Sciences position peaked at $98.7M in Q3 2017.
- 1,568 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.
Based on Holowesko Partners's 13F filing for Q1 2021, filed 13 May 2021.